Fractyl Health, Inc., a burgeoning metabolic therapeutics company, announced that Dr. Harith Rajagopalan, their CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference on Wednesday, May 15, 2024, at 4:20 p.m. PDT (7:20 p.m. EDT). To register for the webcast of the fireside chat, interested individuals can sign up in advance on the company’s website.
Fractyl Health is dedicated to developing innovative treatments for metabolic diseases such as obesity and type 2 diabetes (T2D). Despite significant advances in treatment options, obesity and T2D remain major causes of morbidity and mortality in the modern era. The company’s mission is to shift the focus of metabolic disease treatment from managing symptoms to providing long-lasting therapies that target the root causes of the diseases at an organ level. Fractyl Health is headquartered in Burlington, MA.
For more information about Fractyl Health, individuals can visit their website at www.fractyl.com or follow them on Twitter at https://twitter.com/FractylHealth. The company’s contact information for investors, media inquiries, and corporate communication can be found on their website as well
